Gene · 5648
Papers2,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Air quality modeling in the metropolitan area of São Paulo, Brazil: A review. | Atmos Environ (1994) | 2024 | 38827432 | PubTator, text mining | PubMed |
| Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill. | Curr Issues Mol Biol | 2024 | 38785556 | PubTator, text mining | PubMed |
| Exploring complement biomarkers in suspected axial spondyloarthritis. | RMD Open | 2024 | 38749532 | PubTator, text mining | PubMed |
| Complement MASP-1 Modifies Endothelial Wound Healing. | Int J Mol Sci | 2024 | 38612857 | PubTator, text mining | PubMed |
| Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis. | JCI Insight | 2024 | 38573776 | PubTator, text mining | PubMed |
| Review of Spider Silk Applications in Biomedical and Tissue Engineering. | Biomimetics (Basel) | 2024 | 38534854 | PubTator, text mining | PubMed |
| CL-11 circulates in serum as functionally distinct isoforms. | FASEB J | 2024 | 38466278 | PubTator, text mining | PubMed |
| Systematic analysis of MASP-1 serves as a novel immune-related biomarker in sepsis and trauma followed by preliminary experimental validation. | Front Med (Lausanne) | 2024 | 38384415 | PubTator, text mining | PubMed |
| The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems. | Int J Mol Sci | 2024 | 38338844 | PubTator, text mining | PubMed |
| Serum Olink Proteomics-Based Identification of Protein Biomarkers Associated with the Immune Response in Ischemic Stroke. | J Proteome Res | 2024 | 38319990 | PubTator, text mining | PubMed |
| Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and Thromboxane A2 Receptor. | Int J Mol Sci | 2024 | 38256162 | PubTator, text mining | PubMed |
| Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus. | Cardiovasc Diabetol | 2024 | 38245742 | PubTator, text mining | PubMed |
| An α-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort study. | PLoS Negl Trop Dis | 2024 | 38236916 | PubTator, text mining | PubMed |
| De-stabilizing innate immunity in COVID-19: effects of its own positive feedback and erratic viraemia on the alternative pathway of complement. | R Soc Open Sci | 2024 | 38234438 | PubTator, text mining | PubMed |
| Idiopathic pulmonary fibrosis-specific Bayesian network integrating extracellular vesicle proteome and clinical information. | Sci Rep | 2024 | 38225283 | PubTator, text mining | PubMed |
| Construction of an abnormal glycosylation risk model and its application in predicting the prognosis of patients with head and neck cancer. | Sci Rep | 2024 | 38225277 | PubTator, text mining | PubMed |
| Antibodies to watch in 2024. | MAbs | 2024 | 38178784 | PubTator, text mining | PubMed |
| The complement cascade in lung injury and disease. | Respir Res | 2024 | 38178176 | PubTator, text mining | PubMed |
| Targeted therapies for lupus nephritis: Current perspectives and future directions. | Chin Med J (Engl) | 2024 | 38057972 | PubTator, text mining | PubMed |
| Complement in human disease: approved and up-and-coming therapeutics. | Lancet | 2024 | 37979593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5648/papers?page=6